GLP-1 Drugs May Cut Cancer Risk by 41% — What the Study Found
A 2026 Annals of Oncology study of 229,000+ obese adults found GLP-1 drugs linked to a 41% drop in obesity-related cancer risk. Here's what the data shows, and what to eat to make the most of it.